"The Stanley M. Truhlsen Eye Institute is a state-of-the-art facility that provides the latest in diagnosing and treating all eye care problems. Patients here get the latest and best care in the Midwest thanks in part to Nebraska Medicine's research and education partner, the University of Nebraska Medical Center (UNMC)."

During the past decade, Truhlsen Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Truhlsen Eye Institute" are "Age-related Macular Degeneration" (1 trials), "Glaucoma" (1 trials) and "UVeitis" (1 trials). Many other conditions were trialed in "Truhlsen Eye Institute" in a lesser frequency.

Most popular intervention types in "Truhlsen Eye Institute" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "DCDC App" (1 trials). Other intervention names were less common.

The vast majority of trials in "Truhlsen Eye Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Truhlsen Eye Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Truhlsen Eye Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Truhlsen Eye Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".